ex vivo method for testing whether a patient will respond therapeutically to a treatment method, use of the il10 / ifnt ratio as a biomarker, kit for testing whether a patient will therapeutically respond to a treatment method, and ex vivo method for predicting whether whether or not a patient is likely to survive longer after administration of an immunogenic composition

摘要

The present invention concerns biomarkers and use thereof for determining whether a subject is or is not susceptible to developing a prophylactic or therapeutic immune response after such treatment.